Thyroid report check

• Largest thyroid gene and fusion panel available 1 • Clinically validated and informed by The Cancer Genome Atlas, published literature, and Veracyte R&D discovery using nearly 40,000 samples 1,14 • 593 genes, 905 variants, 235 fusions • Expression signature data associated with variant/fusion findings are included in the report to help predict tumor behavior 14,15 Afirma: Count on a simplified experience • Veracyte is committed to providing patient access, regardless of financial situation • Covered by Medicare 1 • Covered in-network by most commercial payers (over 275 million covered lives) 1 • The Veracyte Access Program supports both eligible uninsured and commercially insured patients with financial need 1 • Get answers quickly, reduce worry and wait 1 • Easily manage patient reports with the Veracyte portal and mobile app • Access the Veracyte portal at portal.veracyte.com • Easily manage patient reports with the Veracyte mobile app • Download the Veracyte app from your mobile app store References: 1. Data on file. 2. Hu M, et al, JCEM, 2021. 3. Patel KN, et al, JAMA Surg, 2018. 4. Ali SZ, et al, Cancer Cytopathol, 2019. 5. Hao Y, et al, BMC Syst Biol, 2019. 6. Angell TE, et al, Thyroid, 2019. 7. San Martin VT, et al, JCEM 2019. 8. Andrioli M, et al, Endocr Pathol, 2020. 9. Wei S, et al, Cancer Cytopathol, 2019. 10. Harrell RM, et al, Endocr Pract, 2018. 11. Endo M, et al, Thyroid, 2019. 12. Goldner W, et al, Thyroid, 2019. 13. Stack, et al, ATA, 2019. 14. TCGA Rese...